Average Co-Inventor Count = 3.23
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Rhone-Poulenc Rorer S.a. (6 from 247 patents)
2. Aventis Pharma S.a. (4 from 377 patents)
3. Other (1 from 832,912 patents)
4. Sanofi-Aventis (1 from 389 patents)
5. Aventis Pharmaceuticals Inc. (1 from 207 patents)
6. Aventis Pharma Limited (1 from 39 patents)
14 patents:
1. 8852878 - Method for identifying an antagonist of guanine nucleotide releasing factor 1
2. 8431119 - Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases
3. 7273854 - Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative disorders
4. 6660757 - Use of riluzole in the treating acoustic traumas
5. 6617316 - Oligosaccharides, their preparation and pharmaceutical compositions containing them
6. 6432992 - Use of riluzole or its salts for the prevention and treatment of adrenoleukodystrophy
7. 6380173 - Use of low-molecular-weight heparins for the prevention and treatment of trauma of the central nervous system
8. 6297254 - Method for the prevention or treatment of a motoneuron disease
9. 5830907 - Application of riluzole in the treatment of neurological lesions
10. 5686475 - Application of riluzole in the treatment of mitochondrial diseases
11. 5674885 - Application of riluzole in the treatment of parkinson's disease and
12. 5658900 - Application of carbamazepine and oxcarbazepine in the treatment of
13. 5656647 - Application of riluzole for promoting restoration following radiation
14. 5502049 - Use of phenothiazine derivatives in the treatment of ischaemia and/or